[PDF] Top 20 Dificultades de Aprendizaje y Trastornos del Desarrollo. Educación Primaria. Prácticas (2019)
Has 10000 "Dificultades de Aprendizaje y Trastornos del Desarrollo. Educación Primaria. Prácticas (2019)" found on our website. Below are the top 20 most common "Dificultades de Aprendizaje y Trastornos del Desarrollo. Educación Primaria. Prácticas (2019)".
Amyloid β-protein oligomers and Alzheimer’s disease
... A successful approach to enable rigorous examination of oligomer structure and toxicity has been photo-induced cross-linking of unmodified proteins (PICUP) (for a review, see [89]). This technique circumvents the ... See full document
33
Adjusting the compass: new insights into the role of angiogenesis in Alzheimer’s disease
... of Alzheimer ’ s disease (AD) have been debated, yet the true cause of this age- related neurological disorder remains ...the amyloid beta (A β ) pla- ques, the dominant hypothesis ... See full document
98
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
... pE-A β oligomers are sufficient to trigger the aggregation of unmodified Aβ1–42, leading to the formation of hypertoxic A β 1 – 42 oligomers ...pE-A β monoclonal anti- body in ... See full document
46
The Alzheimer’s disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathway
... of amyloid-β (Aβ) in amyloid deposits in AD brain and trans- genic animal models of AD [16, 19, ...A β (mixture of different lengths and aggregation states) and ApoE (isoform and lipidation ... See full document
11
Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer’s disease mouse model
... Richmond, CA, USA), according to the molecular weight of the target molecule, transferred onto nitrocellulose membranes (Bio-Rad), and then incubated with appropri- ate primary antibodies as follows: anti-APP N-terminal ... See full document
197
Induced pluripotent stem cells in Alzheimer’s disease: applications for disease modeling and cell-replacement therapy
... including amyloid precursor protein (APP), presenilin-1/ 2 (PSEN1/2) [5, 13], apolipoprotein E (APOE) [14], ABCA7, BIN1, CASS4, CD33, CD2AP, CELF1, CLU, CR1, DSG2, EPHA1, FERMT2, HLA-DRB5-DBR1, INPP5D, ... See full document
45
Identification of the novel activity-driven interaction between synaptotagmin 1 and presenilin 1 links calcium, synapse, and amyloid beta
... AD: Alzheimer ’ s disease; AICD: Amyloid intracellular domain; APP: Amyloid precursor protein; A β : Amyloid β ; BACE1: β -secretase; CHO: Chinese ... See full document
8
Axonal and synaptic pathology in Alzheimer’s disease
... Alzheimer’s disease (AD) remains ...fibrillar β-amyloid (Aβ) as well as intracellular neurofibrillary tangles comprised of hyperphosphorylated tau, that give rise to characteristic dystrophic ... See full document
158
Three-dimensional analysis of synapses in the transentorhinal cortex of Alzheimer’s disease patients
... Alzheimer’s Disease (AD) is the main cause of dementia, accounting for 60−80% of cases in the adult population ...The disease is characterized by a progressive and persistent decline of cognitive functions, ... See full document
39
Deciphering the genesis and fate of amyloid β protein yields novel therapies for Alzheimer disease
... atherosclerotic disease, would include inquiry about a positive family history of AD or a related demen- tia, identification of specific predisposing genetic fac- tors, structural and functional brain imaging to ... See full document
10
Prophylactic melatonin significantly reduces Alzheimer’s neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPPswe/PS1 mice
... A β : Amyloid-beta; A β PP swe : Amyloid-beta precursor protein, human Swedish mutation; AD: Alzheimer ’ s disease; C3B6: Mice with a combination C3H/He and C57BL/6 ... See full document
5
Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease
... A β : amyloid beta-peptide; AD: Alzheimer ’ s disease; APP: amyloid precursor protein; APPsw: Swedish familial Alzheimer ’ s disease mutant isoform of ... See full document
400
Association between total-Tau and brain atrophy one year after first-ever stroke
... A β -42: Amyloid- β peptide-42; AD: Alzheimer ’ s disease; ApoE: Apolipoprotein E genotype; APP: Amyloid precursor protein; CSF: Cerebrospinal fluid; IQ- CODE: ... See full document
67
Cerebral amyloid angiopathy-related inflammation: a case report presenting with a rare variant in SORL1 gene
... to β-amyloid (Aβ) protein in the blood vessel walls [5] and likely responsive to corticosteroid or other immunosuppres- sive agents ...9]. Amyloid-related imaging abnormalities (ARIA) ... See full document
9
The “rights” of precision drug development for Alzheimer’s disease
... A: Amyloid; A β : Amyloid beta protein; AD: Alzheimer ’ s disease; ADAS-cog: AD Assessment Scale-Cognitive subscale; ADCOMS: AD Composite Score; ADCS: Alzheimer ’ ... See full document
20
Adult hippocampal neurogenesis and its role in Alzheimer's disease
... Alzheimer’s disease (AD), first described by the German neuropathologist Alois Alzheimer as Dementia Praecox in 1907, is an age-related neurodegenerative disease characterized by progressive loss of ... See full document
5
The role of APP and BACE1 trafficking in APP processing and amyloid-β generation
... Alzheimer’s disease (AD) is the most common type of ...the amyloid-β protein (Aβ) was isolated from brains with amyloid depositon and it was subsequently identified as the core ... See full document
38
Glutamate receptors function as scaffolds for the regulation of β-amyloid and cellular prion protein signaling complexes
... G protein-coupling spe- cificity and pharmacological profile ...of protein kinase C ...Parkinson’s disease and Huntington’s disease ...Homer/PIKE protein interactions have been ... See full document
24
Cross-talk of membrane lipids and Alzheimer-related proteins
... Epidemiologic studies indicate that statin intake could decrease the risk of developing AD [82-84]. However, a protective role of statins against AD could not be ob- served in other studies. Randomized controlled ... See full document
5
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
... The Norwegian cohort was from the Memory Clinic of Akershus University Hospital in Lørenskog, Norway. The cohort encompassed 50 patients diagnosed with either AD or MCI, due to a pre-dementia stage of AD, and 50 cogni- ... See full document
141
Related subjects